360 related articles for article (PubMed ID: 32226542)
21. 2D Cu-Bipyridine MOF Nanosheet as an Agent for Colon Cancer Therapy: A Three-in-One Approach for Enhancing Chemodynamic Therapy.
Wang C; Xue F; Wang M; An L; Wu D; Tian Q
ACS Appl Mater Interfaces; 2022 Aug; 14(34):38604-38616. PubMed ID: 35979620
[TBL] [Abstract][Full Text] [Related]
22. Tumor Cell Targeting and Responsive Nanoplatform for Multimodal-Imaging Guided Chemodynamic/Photodynamic/Photothermal Therapy toward Triple Negative Breast Cancer.
Li L; Li J; Hu R; Zhang X; Ding L; Ren G; Liu W; Wang H; Wang B; Zhang C; Diao H
ACS Appl Mater Interfaces; 2023 Jun; 15(23):27706-27718. PubMed ID: 37261936
[TBL] [Abstract][Full Text] [Related]
23. Hemoglobin Nanocrystals for Drugs Free, Synergistic Theranostics of Colon Tumor.
Zhou R; Xu H; Qu J; Ohulchanskyy TY
Small; 2023 Feb; 19(8):e2205165. PubMed ID: 36508710
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in multifunctional nanomaterials for photothermal-enhanced Fenton-based chemodynamic tumor therapy.
Manivasagan P; Joe A; Han HW; Thambi T; Selvaraj M; Chidambaram K; Kim J; Jang ES
Mater Today Bio; 2022 Jan; 13():100197. PubMed ID: 35036895
[TBL] [Abstract][Full Text] [Related]
25. Copperphosphotungstate Doped Polyanilines Nanorods for GSH-Depletion Enhanced Chemodynamic/NIR-II Photothermal Synergistic Therapy.
Ye S; Xiao H; Chen J; Zhang D; Qi L; Peng T; Gao Y; Zhang Q; Qu J; Wang L; Liu R
Int J Nanomedicine; 2023; 18():1245-1257. PubMed ID: 36937549
[TBL] [Abstract][Full Text] [Related]
26. Polypyrrole-based nanotheranostic agent for MRI guided photothermal-chemodynamic synergistic cancer therapy.
Zhou B; Yin C; Feng Q; Wu Y; Pan X; Liu C; Tian J; Geng S; Wang K; Xing J; Cao Y; Shou P; Yu Z; Wu A
Nanoscale; 2021 Nov; 13(45):19085-19097. PubMed ID: 34761764
[TBL] [Abstract][Full Text] [Related]
27. Mn doped Prussian blue nanoparticles for T
Tao Q; He G; Ye S; Zhang D; Zhang Z; Qi L; Liu R
J Nanobiotechnology; 2022 Jan; 20(1):18. PubMed ID: 34983564
[TBL] [Abstract][Full Text] [Related]
28. Photothermal nanozymes to self-augment combination cancer therapy by dual-glutathione depletion and hyperthermia/acidity-activated hydroxyl radical generation.
Wang TH; Shen MY; Yeh NT; Chen YH; Hsu TC; Chin HY; Wu YT; Tzang BS; Chiang WH
J Colloid Interface Sci; 2023 Nov; 650(Pt B):1698-1714. PubMed ID: 37499626
[TBL] [Abstract][Full Text] [Related]
29. Mitochondria-Targeting MoS
Li X; Xiao H; Xiu W; Yang K; Zhang Y; Yuwen L; Yang D; Weng L; Wang L
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55928-55938. PubMed ID: 34786942
[TBL] [Abstract][Full Text] [Related]
30. Glucose/Glutathione Co-triggered Tumor Hypoxia Relief and Chemodynamic Therapy to Enhance Photothermal Therapy in Bladder Cancer.
Chen WH; Yu KJ; Jhou JW; Pang HH; Weng WH; Lin WS; Yang HW
ACS Appl Bio Mater; 2021 Oct; 4(10):7485-7496. PubMed ID: 35006706
[TBL] [Abstract][Full Text] [Related]
31. Gold nanoparticles decorated on MOF derived Cu
Thirumurugan S; Dash P; Sakthivel R; Lin YC; Sun YS; Lin CP; Wang AN; Liu X; Dhawan U; Chung RJ
Biomater Adv; 2024 Apr; 158():213778. PubMed ID: 38325029
[TBL] [Abstract][Full Text] [Related]
32. Tumor microenvironment-responsive polydopamine-based core/shell nanoplatform for synergetic theranostics.
Chen Q; Shan X; Shi S; Jiang C; Li T; Wei S; Zhang X; Sun G; Liu J
J Mater Chem B; 2020 May; 8(18):4056-4066. PubMed ID: 32270145
[TBL] [Abstract][Full Text] [Related]
33. Highly Efficient 2D NIR-II Photothermal Agent with Fenton Catalytic Activity for Cancer Synergistic Photothermal-Chemodynamic Therapy.
Zhang Q; Guo Q; Chen Q; Zhao X; Pennycook SJ; Chen H
Adv Sci (Weinh); 2020 Apr; 7(7):1902576. PubMed ID: 32274298
[TBL] [Abstract][Full Text] [Related]
34. NIR-II responsive PEGylated nickel nanoclusters for photothermal enhanced chemodynamic synergistic oncotherapy.
Qian Y; Zhang J; Zou J; Wang X; Meng X; Liu H; Lin Y; Chen Q; Sun L; Lin W; Wang H
Theranostics; 2022; 12(8):3690-3702. PubMed ID: 35664059
[No Abstract] [Full Text] [Related]
35. Pillar[6]arene-Based Supramolecular Nanocatalysts for Synergistically Enhanced Chemodynamic Therapy by the Intracellular Cascade Reaction.
Liu X; Liu J; Meng C; Zhu P; Liu X; Qian J; Ling S; Zhang Y; Ling Y
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53574-53585. PubMed ID: 34729975
[TBL] [Abstract][Full Text] [Related]
36. Bovine serum albumin-templated nanoplatform for magnetic resonance imaging-guided chemodynamic therapy.
Tang W; Gao H; Ni D; Wang Q; Gu B; He X; Peng W
J Nanobiotechnology; 2019 May; 17(1):68. PubMed ID: 31109332
[TBL] [Abstract][Full Text] [Related]
37. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy.
Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J
Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional Magnetic CuS/Gd
Luo M; Yukawa H; Sato K; Tozawa M; Tokunaga M; Kameyama T; Torimoto T; Baba Y
ACS Appl Mater Interfaces; 2022 Aug; 14(30):34365-34376. PubMed ID: 35876015
[TBL] [Abstract][Full Text] [Related]
39. Improving Magnetic Resonance Imaging and Chemodynamic Therapy Properties via Tuning the Fe(II)/Fe(III) Ratio in Hydrophilic Single-Atom Nanobowls.
Luo Q; Ma Q; Liu T; Luo Y; Wang L; Guo C; Wang L
ACS Nano; 2024 Apr; 18(14):10063-10073. PubMed ID: 38533795
[TBL] [Abstract][Full Text] [Related]
40. A tumor-targeted theranostic nanomedicine with strong absorption in the NIR-II biowindow for image-guided multi-gradient therapy.
Chen Q; Zheng Z; He X; Rong S; Qin Y; Peng X; Zhang R
J Mater Chem B; 2020 Oct; 8(41):9492-9501. PubMed ID: 33001118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
